Christopher Von Seggern

Insider Reports History

Entity
Individual
Location
200 3650 Gilmore Way, Burnaby, British Columbia, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Von Seggern:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Chief Commercial Officer Stock Option (Right to Buy) 100K Mar 11, 2024 Direct

Insider Reports Filed by Christopher Von Seggern

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Mar 11, 2024 1 $0 4 Mar 12, 2024 Chief Commercial Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2023 1 $0 4 Mar 14, 2023 Chief Commercial Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 Chief Commercial Officer
XENE Xenon Pharmaceuticals Inc. Dec 6, 2021 1 $97.6K 4 Dec 7, 2021 Chief Commercial Officer